Package 21130-608-20
Brand: pain relief
Generic: naproxen sodiumPackage Facts
Identity
Package NDC
21130-608-20
Digits Only
2113060820
Product NDC
21130-608
Description
200 TABLET in 1 BOTTLE (21130-608-20)
Marketing
Marketing Status
Brand
pain relief
Generic
naproxen sodium
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "fd39cb89-6b3f-69e1-e053-6394a90aff3a", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574"], "spl_set_id": ["eb604ea6-f5c1-156b-e053-2a95a90a76d7"], "manufacturer_name": ["BETTER LIVING BRANDS, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (21130-608-05) / 50 TABLET in 1 BOTTLE", "package_ndc": "21130-608-05", "marketing_start_date": "20230613"}, {"sample": false, "description": "200 TABLET in 1 BOTTLE (21130-608-20)", "package_ndc": "21130-608-20", "marketing_start_date": "20230613"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (21130-608-42) / 24 TABLET in 1 BOTTLE", "package_ndc": "21130-608-42", "marketing_start_date": "20230613"}], "brand_name": "Pain Relief", "product_id": "21130-608_fd39cb89-6b3f-69e1-e053-6394a90aff3a", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "21130-608", "generic_name": "Naproxen sodium", "labeler_name": "BETTER LIVING BRANDS, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Pain Relief", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA090545", "marketing_category": "ANDA", "marketing_start_date": "20230613", "listing_expiration_date": "20261231"}